Supreme Petrochem [SUPPETRO] vs Piramal Pharma [PPLPHARMA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Supreme Petrochem Limited wins in 12 metrics, Piramal Pharma Ltd. wins in 3 metrics, with 0 ties. Supreme Petrochem Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supreme Petrochem Limited | Piramal Pharma Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 150.56 | 269.79 | Supreme Petrochem Limited |
| Price-to-Book Ratio | 5.62 | 2.47 | Piramal Pharma Ltd. |
| Debt-to-Equity Ratio | 0.12 | 60.08 | Supreme Petrochem Limited |
| PEG Ratio | 3.83 | -0.38 | Supreme Petrochem Limited |
| EV/EBITDA | 7.63 | 25.20 | Supreme Petrochem Limited |
| Profit Margin (TTM) | 23.25% | -1.84% | Supreme Petrochem Limited |
| Operating Margin (TTM) | N/A | -0.80% | N/A |
| Return on Equity | 219.17% | 1.12% | Supreme Petrochem Limited |
| Return on Assets (TTM) | 35.86% | 0.58% | Supreme Petrochem Limited |
| Free Cash Flow (TTM) | N/A | $2.28B | N/A |
| Dividend Yield | N/A | 0.07% | N/A |
| 1-Year Return | -6.87% | -16.24% | Supreme Petrochem Limited |
| Price-to-Sales Ratio (TTM) | 1.43 | 2.25 | Supreme Petrochem Limited |
| Enterprise Value | $69.88B | $240.47B | Piramal Pharma Ltd. |
| EV/Revenue Ratio | 1.39 | 2.71 | Supreme Petrochem Limited |
| Gross Profit Margin (TTM) | 22.66% | 63.25% | Piramal Pharma Ltd. |
| Revenue per Share (TTM) | $534 | $67 | Supreme Petrochem Limited |
| Earnings per Share (Diluted) | $70.54 | $-1.23 | Supreme Petrochem Limited |
| Beta (Stock Volatility) | N/A | 0.19 | N/A |
Supreme Petrochem Limited vs Piramal Pharma Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supreme Petrochem Limited | 4.58% | 4.81% | -5.22% | 3.62% | 10.08% | 9.25% |
| Piramal Pharma Ltd. | 0.05% | -4.15% | 4.19% | 9.65% | -8.26% | -1.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supreme Petrochem Limited | -6.87% | 85.30% | -13.54% | 289.94% | 1,035.87% | 2,971.82% |
| Piramal Pharma Ltd. | -16.24% | 115.91% | 3.17% | 3.17% | 3.17% | 3.17% |
Performance & Financial Health Analysis: Supreme Petrochem Limited vs Piramal Pharma Ltd.
| Metric | SUPPETRO | PPLPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹71.68B | ₹199.68B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 6,027 | 2,496,822 |
| 90 Day Avg. Volume | 9,254 | 3,143,094 |
| Last Close | ₹703.05 | ₹167.01 |
| 52 Week Range | ₹460.95 - ₹981.65 | ₹132.30 - ₹220.85 |
| % from 52W High | -28.38% | -24.38% |
| All-Time High | ₹1,027.05 (Mar 28, 2022) | ₹307.90 (Nov 04, 2024) |
| % from All-Time High | -31.55% | -45.76% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | -0.03% |
| Quarterly Earnings Growth | 0.42% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.23% | -0.02% |
| Operating Margin (TTM) | N/A | -0.01% |
| Return on Equity (TTM) | 2.19% | 0.01% |
| Debt to Equity (MRQ) | 0.12 | 60.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹32.19 | ₹61.03 |
| Cash per Share (MRQ) | ₹17.07 | ₹5.63 |
| Operating Cash Flow (TTM) | ₹9.01B | ₹2.44B |
| Levered Free Cash Flow (TTM) | ₹6.63B | ₹911.30M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.07% |
| Last 12-Month Dividend | ₹0.00 | ₹0.14 |
Valuation & Enterprise Metrics Analysis: Supreme Petrochem Limited vs Piramal Pharma Ltd.
| Metric | SUPPETRO (Jun 16, 2025) | PPLPHARMA (Apr 21, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 150.56 | 269.79 |
| Forward P/E | 30.57 | 67.23 |
| PEG Ratio | 3.83 | -0.38 |
| Price to Sales (TTM) | 1.43 | 2.25 |
| Price to Book (MRQ) | 5.62 | 2.47 |
| Market Capitalization | ||
| Market Capitalization | ₹71.68B | ₹199.68B |
| Enterprise Value | ₹69.88B | ₹240.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.39 | 2.71 |
| Enterprise to EBITDA | 7.63 | 25.20 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.19 |
| Book Value per Share (MRQ) | ₹32.19 | ₹61.03 |
Financial Statements Comparison: Supreme Petrochem Limited vs Piramal Pharma Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SUPPETRO | PPLPHARMA (2025) |
|---|---|---|
| Revenue/Sales | N/A | 90.61B |
| Cost of Goods Sold | N/A | 35.72B |
| COGS % of Revenue | - | 39.4% |
| Gross Profit | N/A | 54.89B |
| Gross Margin | - | 60.6% |
| Research & Development | N/A | 971.30M |
| Operating Income (EBIT) | N/A | 6.79B |
| Operating Margin | - | 7.5% |
| EBITDA | N/A | 16.89B |
| EBITDA Margin | - | 18.6% |
| Pre-Tax Income | N/A | 4.15B |
| Pre-Tax Income % of Revenue | - | 4.6% |
| Income Tax | N/A | 3.24B |
| Income Tax % of Revenue | - | 3.6% |
| Net Income (Profit) | N/A | 911.30M |
| Profit Margin | - | 1.0% |
Balance Sheet & Liquidity Metrics
| Metric | SUPPETRO | PPLPHARMA (2025) |
|---|---|---|
| Cash & Equivalents | N/A | 3.69B |
| Total Current Assets | N/A | 57.97B |
| Total Current Assets % of Revenue | - | 64.0% |
| Total Current Liabilities | N/A | 37.66B |
| Total Current Liabilities % of Revenue | - | 41.6% |
| Long-Term Debt | N/A | 33.13B |
| Long-Term Debt % of Revenue | - | 36.6% |
| Total Shareholders Equity | N/A | 81.25B |
| Retained Earnings | N/A | 10.49B |
| Retained Earnings % of Revenue | - | 11.6% |
| Property, Plant & Equipment | N/A | 250.60M |
Cash Flow Statement Comparison
| Metric | SUPPETRO | PPLPHARMA (2025) |
|---|---|---|
| Operating Cash Flow | N/A | 2.44B |
| Operating Cash Flow % of Revenue | - | 2.7% |
| Capital Expenditures | N/A | -6.59B |
| Free Cash Flow | N/A | 2.28B |
| FCF Margin | - | 2.5% |
| Debt Repayment | N/A | -10.65B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUPPETRO | PPLPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 94.02M | 1.32B |
| Float Shares | N/A | 608.76M |
| % Held by Insiders | N/A | 54.54% |
| % Held by Institutions | N/A | 20.41% |
| % Held by Public | N/A | 25.05% |
Dividend Analysis & Yield Comparison: Supreme Petrochem Limited vs Piramal Pharma Ltd.
| Metric | SUPPETRO | PPLPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.14 |
| Last 12-Month Dividend Yield | N/A | 0.07% |
| 3-Year Avg Annual Dividend | ₹9.33 | ₹0.08 |
| 3-Year Avg Dividend Yield | 1.63% | 0.07% |
| 3-Year Total Dividends | ₹28.00 | ₹0.25 |
| Ex-Dividend Date | Jul 25, 2022 | Jul 16, 2025 |